Edge Partners
Edge Partners is a venture capital firm based in Nashville, United States. This profile covers what we know about Edge Partners and how founders can get in front of it in 2026.
Edge Partners is a B2B SaaS focused search fund in the Middle Market and Lower Middle Market Space.
- Location
- Nashville, United States
- Team size
- 1-10
How to pitch Edge Partners
The founders who hear back from Edge Partners lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Edge Partners
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Edge Partners." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/edge-partners
Frequently Asked Questions
What is Edge Partners?
Edge Partners is a venture capital firm based in Nashville, United States. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is Edge Partners based?
Edge Partners is based in Nashville, United States. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Edge Partners?
Unlock a verified email for Edge Partners and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.